Docetaxel, cisplatin and S-1 as first and second-line regimen in patients with unresectable esophageal cancer

Autor:	Tadashi Nishimaki, Hiroyuki Karimata, Yoji Nakamura, Hideaki Shimoji
Rok vydání:	2017
Předmět:	Cisplatin Oncology medicine.medical_specialty business.industry Hematology Unresectable Esophageal Cancer Regimen Second line Internal medicine medicine In patient business medicine.drug
Zdroj:	Annals of Oncology. 28:iii28-iii29
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::dd151368ac4b6712ac01a4d6c091f13a https://doi.org/10.1093/annonc/mdx261.057 Zobrazit plný text záznamu